In a development that has sent a ripple of relief through the corridors of power and a tremor of dread through the bowels of antivaxxers everywhere, the United Kingdom has announced that its domestically brewed Ebola vaccine is entering its final trials. Yes, you heard that correctly. British scientists, presumably fuelled by tea, stoicism, and a profound disregard for their own safety, have managed to concoct a potential antidote to one of nature's most spectacularly unpleasant ways to shuffle off this mortal coil.
Let us pause to consider the magnificence of this moment. While the rest of the world has been busy stockpiling hand sanitiser and arguing about the merits of mask-wearing, the plucky boffins of Blighty have been locked in labs, poking at vials with the sort of reckless abandon that usually precedes a minor explosion or a Nobel Prize. The vaccine, tentatively called 'ChAdOx1 BiEBOV' (because nothing says 'we are very serious scientists' like a name that looks like a cat walked across a keyboard), is based on the same technology that gave us the AstraZeneca COVID-19 jab. Yes, the same one that caused a minor diplomatic kerfuffle with the EU, because apparently even vaccines cannot escape Brexit tensions.
Now, before you start booking your tickets to the next hemorrhagic fever hotspot, a note of caution. Final trials mean exactly that: final. Which implies there were others, and some of those might have involved volunteers who now have interesting new antibodies and possibly a slightly different complexion. But fear not. The British regulatory system, which moves with the speed of a sedated sloth, is already gearing up to approve the vaccine with all due haste. Once it gets past the paperwork, the ethical committees, and the mandatory three-week tea break, it will be deployed to the front lines of global health.
Why does this matter? Because Ebola is the sort of disease that makes COVID-19 look like a mild case of the sniffles. It is a viral haemorrhagic fever that turns your insides to soup and exits via every available orifice. It is the disease that keeps infection control specialists awake at night and has inspired more Hollywood disaster movies than a rogue asteroid. And now, thanks to British ingenuity, we might finally have a way to stop it in its tracks. Or at least slow it down enough to give the rest of us a sporting chance.
The global context is, as ever, a glorious circus of incompetence and panic. Outbreak fears are escalating because, let's face it, we have all just been through a pandemic and we are terminally traumatised. Every cough is now a potential harbinger of doom. Every runny nose is a sign that the Four Horsemen are saddling up. So the timing of this vaccine announcement is impeccable. It is the equivalent of discovering a fire extinguisher just as someone hands you a flamethrower.
But let us not get ahead of ourselves. The final trials will take months, maybe years. And then there is the small matter of manufacturing, distribution, and convincing people to actually take the jab. Given the current climate of vaccine scepticism, we can expect a flurry of YouTube documentaries claiming that the Ebola vaccine contains microchips designed by Bill Gates to track your bowel movements. Because of course we will.
Still, for now, we can raise a glass of lukewarm gin and tonic to the unsung heroes of Porton Down and Oxford. They are the reason we might yet survive the next global health crisis without resorting to living in bunkers and fighting over the last roll of toilet paper. They are the reason that when the headlines scream 'Ebola Outbreak!', the response might not be blind terror but a quiet, British 'Right then, where's the nearest vaccination centre?'
So here is to science, to the NHS, and to the indomitable spirit of a nation that once gave the world the steam engine, the World Wide Web, and now, a cure for one of the most terrifying diseases known to humanity. Just try not to think about what we might have achieved if we had spent less time arguing about Brexit.
